Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference

6 hours ago

EMERYVILLE, Calif., Sept. 19, 2024 ( GLOBE NEWSWIRE ) -- Metagenomi, Inc. ( Nasdaq: MGX ) , a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that company management will participate in the ...

Ticker	Sentiment	Impact
MGX	Neutral	34 %